Products with Alpha-glucosidase inhibitors bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN1635 | Iriflophenone 3-C-beta-D-glucopyranoside |
| 1. Iriflophenone-3- C -glucoside has antioxidant activity, it presents no radical scavenging ability against DPPH , but scavenges ABTS + and peroxyl radicals (TEAC ABTS of 1.04 and TEAC ORAC of 3.61). 2. Iriflophenone-3-C-β-d-glucoside shows potent inhibitory activity against α-glucosidase. 3. Iriflophenone 3-C-β-D-glucoside and mangiferin which along with 3 β taraxerol and other sterols could be contributing to the cholesterol lowering activity. | |
| BCN2053 | Australine |
| 1. Australine is a potent and specific inhibitor of amyloglucosidase. 2. Australine inhibits the glycoprotein processing enzyme glucosidase I, and has slight activity toward glucosidase II. | |
| BCN2054 | Alexine |
| 1. Alexine is a weak inhibitor of glucosidase activity. | |
| BCN2294 | Sophoricoside |
| Sophoricoside has anti-inflammatory, anti-cancer, anti-bone loss, and immunosuppressive effects. Sophoricoside is an effective regulator of lipogenesis and glucose consumption and may find utility in the treatment of obesity and type 2 diabetes. Sophoricoside exposure reduced the number of implanted embryos in a dose-dependent manner and failed the embryo implantation through altering the morphology of uterine and compromising the endometrial receptivity. | |
| BCN2626 | Deoxynojirimycin hydrochloride |
| 1.1-Deoxynojirimycin hydrochloride shows inhibitory activity against α-glucosidases, inhibitors of α-glucosidase are promising candidates for the development of antitype II diabetics and anti-AIDS drugs. | |
